Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease
暂无分享,去创建一个
M. Triggiani | I. Adcock | K. Chung | P. Barnes | K. Varani | M. Contoli | A. Papi | F. Vincenzi | P. Borea | T. Hansel | G. Caramori | E. Leung | S. Maclennan | P. Casolari | A. Tosi | A. Barczyk | P. Barnes | K. Chung
[1] D. J. Schneider,et al. Adenosine signaling and the regulation of chronic lung disease. , 2009, Pharmacology & therapeutics.
[2] Michael R. Blackburn,et al. Enhanced Airway Inflammation and Remodeling in Adenosine Deaminase-Deficient Mice Lacking the A2B Adenosine Receptor1 , 2009, The Journal of Immunology.
[3] Hongwei Yao,et al. Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. , 2009, American journal of respiratory cell and molecular biology.
[4] S. Hodge,et al. Chemotactic Mediators of Th1 T-cell Trafficking in Smokers and COPD Patients , 2009, COPD.
[5] D. Rees,et al. The adenosine a2b receptor: its role in inflammation. , 2008, Endocrine, metabolic & immune disorders drug targets.
[6] S. Srinivasan,et al. Blockade of adenosine A2B receptors ameliorates murine colitis , 2008, British journal of pharmacology.
[7] I. Morita,et al. Protein kinase CK2 is a key activator of histone deacetylase in hypoxia‐associated tumors , 2008, International journal of cancer.
[8] M. Andrades,et al. Oxidative stress in chronic obstructive pulmonary disease patients submitted to a rehabilitation program. , 2007, Respiratory medicine.
[9] Bartolome Celli,et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.
[10] I. Adcock,et al. IL-1β and TNF-α Regulation of the Adenosine Receptor (A2A) Expression: Differential Requirement for NF-κB Binding to the Proximal Promoter1 , 2006, The Journal of Immunology.
[11] Hongyan Zhong,et al. Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. , 2006, The Journal of clinical investigation.
[12] I. Adcock,et al. Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.
[13] H. Schünemann,et al. Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD , 2006, European Journal of Clinical Nutrition.
[14] I. Adcock,et al. IL-1 beta and TNF-alpha regulation of the adenosine receptor (A2A) expression: differential requirement for NF-kappa B binding to the proximal promoter. , 2006, Journal of immunology.
[15] K. Fan Chung. Phosphodiesterase inhibitors in airways disease. , 2006, European journal of pharmacology.
[16] I. Adcock,et al. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. , 2006, The Journal of allergy and clinical immunology.
[17] P. Barnes. Emerging targets for COPD therapy. , 2005, Current drug targets. Inflammation and allergy.
[18] K. Klotz,et al. Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors. , 2005, Biochemical pharmacology.
[19] E. Bateman,et al. Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial , 2005, The Lancet.
[20] K. Klotz,et al. Expression, Pharmacological Profile, and Functional Coupling of A2B Receptors in a Recombinant System and in Peripheral Blood Cells Using a Novel Selective Antagonist Radioligand, [3H]MRE 2029-F20 , 2005, Molecular Pharmacology.
[21] N. Papadopoulos,et al. Oxidants in asthma and in chronic obstructive pulmonary disease (COPD). , 2005, Current pharmaceutical design.
[22] K. Varani,et al. A3 Adenosine Receptor Activation Inhibits Cell Proliferation via Phosphatidylinositol 3-Kinase/Akt-dependent Inhibition of the Extracellular Signal-regulated Kinase 1/2 Phosphorylation in A375 Human Melanoma Cells* , 2005, Journal of Biological Chemistry.
[23] I. Adcock,et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.
[24] A. Papi,et al. Is there a difference between chronic airway inflammation in chronic severe asthma and chronic obstructive pulmonary disease? , 2005, Current opinion in allergy and clinical immunology.
[25] W. MacNee,et al. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.
[26] I. Adcock,et al. Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages , 2004, The Journal of experimental medicine.
[27] I. Adcock,et al. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[28] P. Paré,et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[29] I. Adcock,et al. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. , 2004, Biochemical and biophysical research communications.
[30] D. Schrijvers,et al. Nucleofection as an efficient nonviral transfection method for human monocytic cells , 2003, Biotechnology Letters.
[31] S. Bozinovski,et al. Acquired somatic mutations in the molecular pathogenesis of COPD. , 2003, Trends in pharmacological sciences.
[32] K. Varani,et al. The FASEB Journal express article 10.1096/fj.02-0543fje. Published online December 3, 2002. Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation , 2022 .
[33] I. Adcock,et al. Increased p21(CIP1/WAF1) and B cell lymphoma leukemia-x(L) expression and reduced apoptosis in alveolar macrophages from smokers. , 2002, American journal of respiratory and critical care medicine.
[34] W. Bailey,et al. Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.
[35] B. Cronstein,et al. Inflammatory Cytokines Regulate Function and Expression of Adenosine A2A Receptors in Human Monocytic THP-1 Cells1 , 2001, The Journal of Immunology.
[36] I. Adcock,et al. p65-activated Histone Acetyltransferase Activity Is Repressed by Glucocorticoids , 2001, The Journal of Biological Chemistry.
[37] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[38] S. Hotop,et al. Peroxidative stress selectively down‐regulates the neuronal stress response activated under conditions of endoplasmic reticulum dysfunction , 2001, Journal of neurochemistry.
[39] L. Fabbri,et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[40] I. Adcock,et al. Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12 , 2000, Molecular and Cellular Biology.
[41] K. Klotz,et al. [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. , 2000, Molecular pharmacology.
[42] P. Hiemstra,et al. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD , 2000, The Journal of pathology.
[43] K. Klotz,et al. [3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. , 2000 .
[44] J E Cotes,et al. Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.
[45] J E Cotes,et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.
[46] G. Dewald,et al. Establishment of an immature mast cell line from a patient with mast cell leukemia. , 1988, Leukemia research.
[47] D Rodbard,et al. Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.
[48] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.